Delivery Order SPE2DB22D1017-SPE2DB24FG4UU
Award Date
9/10/24
Potential Completion Date
9/11/24
Potential Value
$1.6K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was made by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a large pharmaceutical distributor, for the supply of Budesonide-Formoterol 160-4.5 10.2GM, a respiratory medication. The contract is a delivery order with a firm fixed price of $32,065.91 and an ultimate completion date of September 27, 2024. This award is not set aside and is part of a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The $3,789.30 firm fixed price delivery order is for the supply of budesonide-formoterol 160-4.5 10.2GM, a prescription medication. The contract has an ultimate completion date of September 13, 2024. Amerisourcebergen is the prime contractor and no set-aside designation is mentioned. This contract award appears to be part of a...
This federal contract award, valued at $14,295.01, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is a delivery order contract for the supply of Budesonide-Formoterol 80-4.5 10.2GM, a pharmaceutical product, with a performance period extending through May 8, 2025. The contract is a firm fixed-price, non-set-aside arrangement, indicating open competition. Amerisourcebergen Drug Corp...
This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is for the delivery of Budesonide-Formoterol 80-4.5 10.2 GM, a pharmaceutical product, with a ceiling value of $3,540.00 and an ultimate completion date of November 21, 2023. The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) valued at $999,999,999 that Amerisourcebergen holds with the...
This federal contract award, valued at $2,362.81, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award covers the delivery of budesonide-formoterol 160-4.5 10.2GM, a pharmaceutical product, with a completion date of July 3, 2024. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA, valued at...
This federal contract award to Amerisourcebergen Drug Corp is a delivery order under the Defense Logistics Agency (DLA) Troop Support Medical Indefinite Delivery Contract, valued at up to $999,999,999 through December 2025. The contract provides for the supply of a pharmaceutical product, Budesonide-Formoterol 160-4.5 10.2GM, to support military treatment facilities and programs. The fixed-price delivery order has a ceiling value of $1,501.77 and an ultimate completion date of August 27, 2024....
The U.S. Department of Defense's Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order contract to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation. The contract, valued at $1,515.72, is for the delivery of Budesonide-Formoterol 160-4.5 10.2GM, a pharmaceutical product. This order is part of a larger indefinite delivery contract (IDC) awarded solely to AmerisourceBergen Drug Corp, with a potential value of $999,999,999.00 and a...
This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major supplier of pharmaceutical products and medical supplies to the U.S. government. The contract, valued at $1,515.72, is a delivery order for the supply of Budesonide-Formoterol 160-4.5 10.2GM, a respiratory medication. This contract is not designated as a set-aside and will be completed by August 21, 2024. AmerisourceBergen holds a large Indefinite Delivery Contract (IDC) with the...
This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order valued at $1,709.60 with a Firm Fixed Price pricing type. The award is for the supply of Budesonide-Formoterol 160-4.5 10.2GM, a pharmaceutical product. The contract has an ultimate completion date of March 27, 2025. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC)...
This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of Budesonide-Formoterol 80-4.5 10.2GM, a pharmaceutical product. The Firm Fixed Price delivery order contract, valued at $1,047.99, has a period of performance through September 4, 2024. This award is part of a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA Troop Support Medical, valued at up to...